At 35, Katie Dutton is already a rectal cancer survivor, an ordeal that started with seemingly benign symptoms doctors initially dismissed. She was told to change her diet and was treated for ...

The main objective of the proposed randomized study is to compare the cost-effectiveness and cost-utility of TEM and EMR for the removal of large rectal adenomas. For a cost-effectiveness and cost ...

We have helped pioneer procedures such as transanal endoscopic microsurgery (TEM) and transanal minimally-invasive surgery ... We are dedicated to patient-centered, multidisciplinary care that ...

In 2025, the American Cancer Society estimates 107,320 new cases of colon cancer and 46,950 new cases of rectal cancer will be diagnosed in the United States. They also expect 52,900 people to die ...

rectal or prostate. For that reason it is not part of the routine physical examination. However, a DRE might be included as a part of prostate cancer screening. This will depend on your age ...

On February 21, Tempus AI, Inc. (NASDAQ:TEM) partnered with Menarini Group and its subsidiary, Stemline Therapeutics, to improve metastatic breast cancer care using its AI-powered Next platform.

"These cancers can also be called colon cancer or rectal cancer, depending on where they start. Colon cancer and rectal cancer are often grouped together because they have many features in common." ...

People with rectal cancer could be spared the need for life-changing surgery thanks to a rapid treatment that preserves healthy tissue, a clinical trial has found. Experts at the NHS Clatterbridge ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other AI stocks worth taking a look at. In a Bloomberg interview, SandboxAQ CEO Jack Hidary ...